AI Insight: Somnigroup’s current price exceeds the PERT-weighted fair value by 11.5%, indicating potential overvaluation amid mixed valuation methods; analyst targets and trading range suggest higher upside. Financial health scores reveal profitability strength but weak leverage and growth metrics, increasing risk. Monte Carlo outputs show high volatility and considerable downside scenarios (55.6%), reflecting investment uncertainty.